Health In Tech, a leading insurtech company traded on Nasdaq under the ticker HIT, has announced plans to release its third quarter 2025 financial results on November 10, following the close of market trading. The disclosure will cover the period ending September 30, 2025, and is expected to provide detailed insights into the performance of its innovative insurtech platform, along with updates on its ongoing integration of artificial intelligence technologies. Investors and industry observers are eagerly anticipating this report, as it comes amid a period of rapid growth for the company and increasing adoption of AI-driven solutions in the healthcare insurance sector.
Founded as an insurtech platform company, Health In Tech specializes in streamlining self-funded health plans for small to medium-sized businesses. The company’s core offerings include reference-based pricing, group insurance captives, and community-rated plans, all facilitated through a dynamic online marketplace that connects insurers, brokers, employers, and employees. By leveraging third-party AI technology, Health In Tech aims to create customized, efficient health insurance solutions that reduce costs and improve accessibility. This marketplace approach allows insurance companies to list their products while enabling quick quoting and binding of plans, often in minutes, through tools like its eDIYBS system.
The company’s recent financial trajectory has been impressive, setting the stage for what could be another strong quarter. In the second quarter of 2025, Health In Tech reported total revenues of $9.3 million, marking an 86% increase year-over-year. This growth contributed to first-half revenues of $17.3 million, which already represented 89% of the company’s full-year 2024 total of approximately $19.5 million. Net income for the first half surged to $1.13 million, up significantly from the previous year, driven by expanded enrollment and operational efficiencies. Similarly, the first quarter saw revenues climb to $8 million, a 56% rise from the prior year, with pre-tax income jumping 257% to $0.7 million. These figures underscore the company’s momentum in capturing market share within the self-funded insurance space, where employers bear the financial risk but gain flexibility in plan design.
Analysts expect the third quarter results to build on this foundation, potentially highlighting continued revenue expansion fueled by new partnerships and platform enhancements. Key metrics to watch include billed enrolled employees, which have been a strong indicator of growth in prior reports, as well as updates on cash positions and accounts receivable. As of the end of the first quarter, cash and equivalents stood at $7.6 million, providing a solid buffer for ongoing investments in technology. The earnings release will be followed by a conference call at 5:00 p.m. Eastern Time on November 10, where executives are likely to discuss these numbers in detail and field questions from investors.
A significant focus of the upcoming report is expected to be on the performance of Health In Tech’s insurtech platform, particularly its AI integrations that are transforming self-funded healthcare. The platform utilizes AI for data analytics, machine learning, and predictive modeling to process vast datasets from medical records, wearables, and genetic profiles, enabling personalized treatment plans and risk assessments. Proprietary tools like the HI Performance Network enhance transparency in health spending, while the HI Card provides round-the-clock access to patient data, reducing administrative burdens and billing redundancies. These features have proven effective in cutting costs for employers, with AI-driven predictive algorithms forecasting health risks and utilization patterns to support preventive care and efficient budgeting.
Recent developments further emphasize Health In Tech’s commitment to AI. In September 2025, the company strengthened its leadership team by appointing a new Chief Technology Officer with extensive experience in AI and machine learning, tasked with accelerating innovation in predictive analytics and personalized care tools. A Vice President of AI Strategy was also hired to lead expansions in natural language processing for medical records and automated diagnostics, aiming to boost platform efficiency and enterprise revenue. Earlier in the year, partnerships with organizations like Vitable and MARPAI were announced to leverage AI-powered platforms for self-funded health plans, focusing on direct primary care and technology-driven administration. These moves align with broader industry trends, where AI is projected to revolutionize insurance by improving risk assessment, underwriting, and claims processing.
The integration of AI not only enhances operational efficiency but also addresses key challenges in healthcare, such as inconsistent pricing and lack of transparency. By synthesizing data for tailored interventions, Health In Tech’s platform shifts the paradigm from generic to patient-centered care, empowering users with informed choices and proactive health management. Surveys indicate that 78% of healthcare professionals see improvements in administrative processes due to AI, freeing up time for better patient interactions. For small businesses, this means substantial cost savings and reduced financial risks associated with self-funded plans.
Looking ahead, the third quarter results could signal Health In Tech’s readiness for further scalability. The company is finalizing a large-group AI-powered underwriting platform, expected to roll out soon, which could open new revenue streams. With post-IPO momentum and a focus on AI-driven solutions, Health In Tech is positioning itself as a blueprint for the future of insurtech. Industry events, such as the upcoming Davos 2026 panel featuring prominent figures, will showcase enhancements like the Enhanced Do It Yourself Benefit System, further highlighting AI’s role in women’s health and broader innovation.
Market sentiment remains positive, with the company’s stock reacting favorably to prior earnings beats, such as the 6.67% surge following Q2 results. However, forward-looking statements in the release will likely include disclaimers about risks, including regulatory changes and market volatility. As the insurtech sector evolves, Health In Tech’s blend of AI and self-funded models could drive sustained growth, benefiting stakeholders through cost-effective, transparent healthcare solutions.
In the broader context, this earnings release arrives as the healthcare industry grapples with rising costs and the need for digital transformation. Competitors like Hims & Hers and Hinge Health have reported strong Q3 growth, with revenues up 49% and 53% respectively, underscoring the demand for tech-enabled health services. Health In Tech’s focus on AI positions it well to capitalize on these trends, potentially leading to increased adoption and partnerships.
Ultimately, the November 10 announcement will offer a window into how effectively the company is executing its strategy, balancing innovation with financial discipline in a competitive landscape. Investors should tune into the earnings call for deeper insights into AI initiatives and long-term projections, as Health In Tech continues to disrupt traditional insurance models.
The company’s journey reflects the broader shift toward AI in insurance, where generative AI and synthetic data are enhancing underwriting and personalization. By prioritizing patient empowerment and cost optimization, Health In Tech is not just reporting numbers but shaping the future of accessible healthcare. As the report unfolds, it may reinforce the company’s role as a key player in insurtech’s AI revolution.
